14 studies were found.

1.		Recruiting	3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Biliary Duct or Gallbladder Cancer Conditions: unresectable extrahepatic bile duct cancer; recurrent gallbladder cancer; unresectable gallbladder cancer; recurrent extrahepatic bile duct cancer; ...
2.		Recruiting	Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach Conditions: adenocarcinoma of the stomach; recurrent gastric cancer; stage III gastric cancer; stage IV gastric cancer
3.		Recruiting	Celecoxib, Paclitaxel, and Carboplatin in Treating Patients With Cancer of the Esophagus Conditions: Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus; stage I esophageal cancer; stage II esophageal cancer; ...
4.		Recruiting	Combination Chemotherapy Plus Erlotinib in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer Conditions: Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
5.		Recruiting	FR901228 in Treating Patients With Relapsed or Refractory Multiple Myeloma Conditions: stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm
6.		Recruiting	FR901228 in Treating Patients With Unresectable Recurrent or Metastatic Squamous Cell Carcinoma (Cancer) of the Head and Neck Condition: Head and Neck Cancer
7.		Recruiting	Oblimersen, Cisplatin, and Fluorouracil in Treating Patients With Advanced Esophageal, Gastroesophageal Junction, or Stomach Cancer Conditions: Esophageal Cancer; Gastric Cancer
8.		Recruiting	Oxaliplatin and Bortezomib in Treating Patients With Advanced Cancer Condition: unspecified adult solid tumor, protocol specific
9.		Recruiting	Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer Conditions: recurrent cervical cancer; stage IVA cervical cancer; stage IVB cervical cancer; cervical adenosquamous cell carcinoma; ...
10.		Recruiting	PKC412 in Patients with Acute Myeloid Leukemia and Patients with Myelodysplastic Syndrome with either Wild Type or Mutated FLT3 Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndromes
11.		Recruiting	SGN-00101 Immunotherapy in Treating Patients With Grade III Cervical Intraepithelial Neoplasia Condition: Cervical Cancer
12.		Recruiting	Thalidomide With or Without Fludarabine in Treating Patients With Hematologic Cancer Conditions: refractory chronic lymphocytic leukemia; recurrent small lymphocytic lymphoma
13.		Recruiting	Tipifarnib and Fulvestrant as Second-Line Therapy in Treating Postmenopausal Women With Hormone Receptor-Positive Inoperable Locally Advanced or Metastatic Breast Cancer With Progressive Disease After Previous First-Line Endocrine Therapy Conditions: recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
14.		Recruiting	Tretinoin Plus Interferon alfa in Treating Patients With Metastatic Kidney Cancer Conditions: Stage IV Renal Cell Cancer; recurrent renal cell cancer